Literature DB >> 29306063

Many randomized clinical trials may not be justified: a cross-sectional analysis of the ethics and science of randomized clinical trials.

Julie De Meulemeester1, Mark Fedyk2, Lucas Jurkovic1, Michael Reaume1, Dar Dowlatshahi3, Grant Stotts3, Michel Shamy4.   

Abstract

OBJECTIVE: We have proposed that three scientific criteria are important for the ethical justification of randomized clinical trials (RCTs): (1) they should be designed around a clear hypothesis; (2) uncertainty should exist around that hypothesis; (3) that uncertainty should be as established through a systematic review. We hypothesized that the majority of a sample of recently published RCTs would not explicitly incorporate these criteria, therefore rendering them potentially unjustified on scientific grounds. STUDY DESIGN AND
SETTING: Cross-sectional analysis of all RCTs published in the New England Journal of Medicine and the Journal of the American Medical Association in 2015. Each article and protocol was reviewed for: (1) a clearly stated central hypothesis; (2) references to "equipoise," or "consensus;" (3) some indication of evidentiary uncertainty; (4) a meta-analysis or systematic review surrounding the hypothesis or study question.
RESULTS: We included 208 RCT articles and 199 protocols. Among combined articles and protocols, 76% had a clearly stated hypothesis, 99% referenced some form of uncertainty, and 54% cited a relevant systematic review or meta-analysis. Only 44% of combined texts contained all three scientific criteria. There were few references to "equipoise" (10%) or "consensus" (11%), and those references to equipoise were most often inconsistent with accepted definitions.
CONCLUSION: The majority of RCTs (56%) did not meet the three scientific criteria described previously and therefore may be scientifically and therefore ethically unjustified. We recommend that "equipoise," "clinical equipoise," and "lack of consensus" be abandoned as scientific criteria for RCTs and be replaced by an expectation that RCTs have a clearly stated, meaningful hypothesis around which uncertainty has been established through a systematic review of the literature.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Keywords:  Cross-sectional analysis; Epistemology; Equipoise; Ethics; Justification; Randomized controlled trials

Mesh:

Year:  2018        PMID: 29306063     DOI: 10.1016/j.jclinepi.2017.12.027

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  7 in total

1.  Conditional power of antidepressant network meta-analysis.

Authors:  Lisa Holper
Journal:  BMC Psychiatry       Date:  2021-03-05       Impact factor: 3.630

2.  Intervention development and treatment success in UK health technology assessment funded trials of physical rehabilitation: a mixed methods analysis.

Authors:  Victoria A Goodwin; Jacqueline J Hill; James A Fullam; Katie Finning; Claire Pentecost; David A Richards
Journal:  BMJ Open       Date:  2019-08-28       Impact factor: 2.692

3.  Many trials of hydroxychloroquine for SARS-CoV-2 were redundant and potentially unethical: an analysis of the NIH clinical trials registry.

Authors:  Vignan Yogendrakumar; Brian Dewar; Michaeline McGuinty; Dar Dowlatshahi; Claire Dyason; Edmond Sh Kwok; Tim Ramsay; Hans Lund; Michel Shamy
Journal:  J Clin Epidemiol       Date:  2021-11-13       Impact factor: 7.407

4.  Are orthodontic randomised controlled trials justified with a citation of an appropriate systematic review?

Authors:  Kishan Patel; Martyn T Cobourne; Nikolaos Pandis; Jadbinder Seehra
Journal:  Prog Orthod       Date:  2021-12-17       Impact factor: 2.750

5.  Comparability of Biologics: Global Principles, Evidentiary Consistency and Unrealized Reliance.

Authors:  Christopher J Webster; Kelly L George; Gillian R Woollett
Journal:  BioDrugs       Date:  2021-06-18       Impact factor: 5.807

6.  An Efficient Development Paradigm for Biosimilars.

Authors:  Christopher J Webster; Anny C Wong; Gillian R Woollett
Journal:  BioDrugs       Date:  2019-12       Impact factor: 5.807

7.  Redundant trials can be prevented, if the EU clinical trial regulation is applied duly.

Authors:  Daria Kim; Joerg Hasford
Journal:  BMC Med Ethics       Date:  2020-10-28       Impact factor: 2.652

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.